{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T04:29:08Z","timestamp":1648960148961},"reference-count":125,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1157\/13108710","type":"journal-article","created":{"date-parts":[[2007,8,13]],"date-time":"2007-08-13T15:06:34Z","timestamp":1187017594000},"page":"467-476","source":"Crossref","is-referenced-by-count":3,"title":["Espectro y factores de riesgo de la infecci\u00f3n f\u00fangica invasora"],"prefix":"10.1016","volume":"25","author":[{"given":"Juan Jos\u00e9","family":"Cast\u00f3n Osorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"Torre-Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13108710_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes","volume":"79","author":"Patterson","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1157\/13108710_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/376906","article-title":"A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalizad adult and pediatric patients","volume":"37","author":"Pappas","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic item cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/322606","article-title":"Trends in mortality due to invasive mycotic diseases in the United Status, 1980-1997","volume":"33","author":"Mc Neil","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib6","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1128\/JCM.37.6.1732-1738.1999","article-title":"Epidemiology of visceral mycoses: analysis of data in Annual of the Pathological Autopsy Cases in Japan","volume":"37","author":"Yamazaki","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Atritutable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/infdis\/167.5.1247","article-title":"Secular trends in the epidemiology of nosocomial fungal infections in the United Status, 1980-1990: Nacional Nosocomial Infections Surveillance System","volume":"167","author":"Beck-Sague","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1157\/13108710_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: a three-year analysis","volume":"29","author":"Edmon","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/342300","article-title":"Secular Trend of Hospital-Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989-1999","volume":"35","author":"Trick","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0025-7753(02)72513-X","article-title":"Etiolog\u00eda de las infecciones hospitalarias en Espa\u00f1a (EPINE, 1990-1999)","volume":"118","author":"Asensio","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13108710_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(91)90349-3","article-title":"Secular trends in nosocomial primary bloodstream infections in the United States","volume":"91","author":"Banerjee","year":"1991","journal-title":"Am J Med"},{"key":"10.1157\/13108710_bib13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/infdis\/167.5.1247","article-title":"Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990","volume":"167","author":"Beck-Sague","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1157\/13108710_bib14","doi-asserted-by":"crossref","unstructured":"Voss A, Kluytmans JA, Koeleman L, Spanjaard L, Vandenbroucke-Grauls CM, Verbrugh HA, et al. Ocurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis. 1006;15:909-12.","DOI":"10.1007\/BF01690507"},{"key":"10.1157\/13108710_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib16","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/JCM.36.12.3455-3459.1998","article-title":"Constant low rate of fungemia in Norway, 1991 to 1996","volume":"36","author":"Sandven","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib17","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1128\/JCM.40.9.3489-3492.2002","article-title":"Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland","volume":"40","author":"Asmundsdottir","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib18","first-page":"985","article-title":"Candidemia in Finland","volume":"9","author":"Poikone","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1157\/13108710_bib19","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/JCM.43.9.4434-4440.2005","article-title":"Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility","volume":"43","author":"Arendrup","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib20","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib21","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro surveillance of isolates collected from 1998 to 2000 in a population-based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent proteccion against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1157\/13108710_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200201150-00011","article-title":"Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices","volume":"73","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"10.1157\/13108710_bib24","first-page":"30","article-title":"Estudio multic\u00e9ntrico sobre la epidemiolog\u00eda de las candidemias en Espa\u00f1a","volume":"19","author":"Pem\u00e1n","year":"2002","journal-title":"Rev Iberoam Micol"},{"issue":"Suppl 1","key":"10.1157\/13108710_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1470-9465.2004.t01-1-00844.x","article-title":"Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida","volume":"10","author":"Pfaller","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1157\/13108710_bib26","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1128\/JCM.25.6.1029-1032.1987","article-title":"Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers","volume":"25","author":"Weems","year":"1987","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib27","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1001\/archinte.137.12.1686","article-title":"Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous insufions","volume":"137","author":"Plouffe","year":"1977","journal-title":"Arch Inter Med"},{"key":"10.1157\/13108710_bib28","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/clinids\/14.3.756","article-title":"Candida parapsilosis: epidemiology, pathogenecity, clinical manifestations, and antimicrobial susceptibility","volume":"14","author":"Weems","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1157\/13108710_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/clinids\/22.Supplement_2.S89","article-title":"Nosocomial candidiasis: emerging sepecies, reservoirs, and modes of transmission","volume":"22","author":"Pfaller","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib30","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1128\/JCM.33.5.1368-1370.1995","article-title":"Taxonomic position of deep-seated, mucosa associated, and superficial isolates of Trichosporon cutaneum fron trichosporonosis patients","volume":"33","author":"Sugita","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib31","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/JCM.42.10.4419-4431.2004","article-title":"Rare and emerging opportunistic fungal pathogens: concerni for resistance beyond Candida albicans and Aspergillus fumigatus","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"10.1157\/13108710_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1470-9465.2004.00839.x","article-title":"Infections due to emerging and uncommon medically important fungal pathogens","volume":"10","author":"Walsh","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1157\/13108710_bib33","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.43.4.1818-1828.2005","article-title":"Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignances: a retrospective multicenter study from Italy and review of the literature","volume":"43","author":"Girmenia","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib34","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1128\/JCM.28.7.1616-1622.1990","article-title":"Trichosporon beigelii: an emerging pathogen resistant to amphotericin B","volume":"28","author":"Walsh","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib35","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/AAC.46.4.1144-1146.2002","article-title":"In vitro antifungal susceptibilities of Trichosporon species","volume":"46","author":"Paphitou","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13108710_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/AAC.44.1.57-62.2000","article-title":"In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi","volume":"44","author":"Tawara","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13108710_bib37","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1128\/AAC.41.5.1156","article-title":"In vitro activity of a anew echinocandin, LY303366, compared with tose of amphotericin B and fluconazole against clinical yeast isolates","volume":"41","author":"Uzun","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13108710_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/500323","article-title":"Breakthrough trichosporonosis in patients with hematological malignancies receiving micafungin","volume":"42","author":"Matsue","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1128\/JCM.25.7.1191-1194.1987","article-title":"DNA, relatedness, taxonomy, and medical significance of Geotrichum capitatum","volume":"25","author":"Gueho","year":"1987","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/A:1001762024710","article-title":"Dipodascus capitatus, Dipodascus spicifer and Geotrichum clavatum: genomic characterizacion","volume":"74","author":"Smith","year":"1998","journal-title":"Antonie Leeuwnhoek"},{"key":"10.1157\/13108710_bib41","first-page":"375","article-title":"Blastoschizomyces capitatus, a new combination","volume":"22","author":"Salkin","year":"1985","journal-title":"Mycotaxon"},{"issue":"Suppl 1","key":"10.1157\/13108710_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1470-9465.2004.00842.x","article-title":"Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp","volume":"10","author":"Bouza","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1157\/13108710_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/infdis\/147.2.199","article-title":"Colonization and infection with Trichosporon species in the inmunosuppressed host","volume":"147","author":"Haupt","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1157\/13108710_bib44","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients. A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib45","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/JCM.34.3.753-755.1996","article-title":"Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients","volume":"34","author":"D\u2019Antonio","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.36.1.198-202.1998","article-title":"In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/1120009X.1991.11739056","article-title":"In vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus","volume":"3","author":"Venditti","year":"1991","journal-title":"J Chemother"},{"key":"10.1157\/13108710_bib48","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1128\/JCM.42.4.1832-1836.2004","article-title":"Genotyping and antifungal susceptibility profile of Dipodascus capitatus isolates causing disseminated infection in seven hematological patients of a tertiary hospital","volume":"42","author":"Gadea","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0002-9343(83)91216-0","article-title":"Rhodotorula rubra peritonitis in patients undergoing continuous ambulatory peritoneal dialysis","volume":"75","author":"Eisenberg","year":"1983","journal-title":"Am J Med"},{"key":"10.1157\/13108710_bib50","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/JCM.41.2.857-859.2003","article-title":"Cateter-related sepsis due to Rhodotorula glutinis","volume":"41","author":"Hsueh","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/JCM.39.1.410.2001","article-title":"Rhodotorula glutinis-related meningitis","volume":"39","author":"Lanzafame","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00916440","article-title":"Rhodotorula glutinis keratitis","volume":"16","author":"Guerra","year":"1992","journal-title":"Int Ophtalmol"},{"key":"10.1157\/13108710_bib53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/507036","article-title":"Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital","volume":"43","author":"Lunardi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib54","unstructured":"Diekema DJ, Petroelje B, Messer A, Hollis RJ, Pfaller MA. Activity of available and investigational antifungal agents against Rhodotorula species. J Clin Microbiol (en prensa)."},{"key":"10.1157\/13108710_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1007059005753","article-title":"Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples","volume":"145","author":"Gal\u00e1n-S\u00e1nchez","year":"1999","journal-title":"Mycopaphologia"},{"key":"10.1157\/13108710_bib56","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1128\/JCM.41.11.5233-5235.2003","article-title":"Risk of fungemia due to Rhodororula and antifungal susceptibility testing of Rhodotorula isolates","volume":"41","author":"Zaas","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib57","unstructured":"National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 2nd ed. M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa."},{"key":"10.1157\/13108710_bib58","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/jac\/dki020","article-title":"Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review","volume":"55","author":"G\u00f3mez-L\u00f3pez","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13108710_bib59","series-title":"Tratado SEIMC de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","first-page":"653","article-title":"Infecciones por Fusarium y Scedosporium. Otras hialohifomicosis y feohifomicosis","author":"Cuenca-Estrella","year":"2006"},{"key":"10.1157\/13108710_bib60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/380635","article-title":"Primary central nervous system phaehyphomycosis: a review of 101 cases","volume":"38","author":"Revankar","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/B:MYCO.0000003563.29320.95","article-title":"Phaeohyphomycosis caused by Chaetomium globosum in an allogeneic bone marrow transplant recipient","volume":"156","author":"Teixeira","year":"2003","journal-title":"Mycopathologia"},{"issue":"Suppl 2","key":"10.1157\/13108710_bib62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1179\/joc.2003.15.Supplement-2.36","article-title":"Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi","volume":"15","author":"Brandt","year":"2003","journal-title":"J Chemother"},{"key":"10.1157\/13108710_bib63","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/clinids\/24.3.369","article-title":"Infections due to dematiaceous fungi in organ transplant recipients: case report and review","volume":"24","author":"Singh","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib64","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/00007890-200112150-00023","article-title":"Alternariosis after liver transplantation","volume":"72","author":"Benito","year":"2001","journal-title":"Transplantation"},{"key":"10.1157\/13108710_bib65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.TP.0000107287.70512.E7","article-title":"Subcutaneous black fungus (phaeohyphomycosis) infection in renal transplant recipients: three cases","volume":"77","author":"Yehia","year":"2004","journal-title":"Transplantation"},{"key":"10.1157\/13108710_bib66","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00001432-200112000-00003","article-title":"Emergence of black moulds in fungal disease: epidemiology and therapy","volume":"14","author":"Silveria","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"10.1157\/13108710_bib67","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1128\/JCM.36.8.2353-2355.1998","article-title":"In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications","volume":"36","author":"McGinnis","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib68","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0190-9622(90)70259-K","article-title":"Itraconazole treatment of phaehyphomycosis","volume":"23","author":"Sharkey","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1157\/13108710_bib69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/02681219880000371","article-title":"In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi","volume":"36","author":"Mc Guinnis","year":"1998","journal-title":"Med Mycol"},{"key":"10.1157\/13108710_bib70","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.36.10.2950-2956.1998","article-title":"Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-09991 (L743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeast","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13108710_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-4453(96)92700-0","article-title":"Trends in post-mortem epidemiology of invasive fungal infections at a university hospital","volume":"33","author":"Groll","year":"1996","journal-title":"J Infect"},{"key":"10.1157\/13108710_bib72","first-page":"211","article-title":"Aspergillus rising frecuency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999","volume":"41","author":"Chandrasekar","year":"2001","journal-title":"Mycology"},{"key":"10.1157\/13108710_bib73","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005792-199807000-00003","article-title":"The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis","volume":"77","author":"Van Burik","year":"1998","journal-title":"Medicine"},{"key":"10.1157\/13108710_bib74","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1086\/339946","article-title":"Why prior fluconazole use is associated with a increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypotesis?","volume":"34","author":"Kontoyiannis","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib75","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1086\/323895","article-title":"Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices","volume":"33","author":"Singh","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib76","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/cc3488","article-title":"Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome","volume":"9","author":"Garnacho-Montero","year":"2005","journal-title":"Crit Care"},{"key":"10.1157\/13108710_bib77","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1157\/13108710_bib78","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1086\/319985","article-title":"Invasive mold infections in allogeneic bone marrow transplant recipients","volume":"32","author":"Baddley","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib79","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1086\/520297","article-title":"Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature","volume":"26","author":"Iwen","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib80","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/421950","article-title":"Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases","volume":"39","author":"Steinbach","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1378\/chest.06-0767","article-title":"Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi","volume":"131","author":"Cast\u00f3n","year":"2007","journal-title":"Chest"},{"key":"10.1157\/13108710_bib82","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2141.2005.05763.x","article-title":"Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience","volume":"131","author":"Lass-Fl\u00f6rl","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1157\/13108710_bib83","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00001432-200208000-00001","article-title":"Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the Picture?","volume":"15","author":"Junghanss","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"10.1157\/13108710_bib84","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","article-title":"Allogeneic blood and bone-marow stem-cell transplantation in haematological malignant diseases: a randomized trial","volume":"355","author":"Powles","year":"2000","journal-title":"Lancet"},{"key":"10.1157\/13108710_bib85","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1702226","article-title":"Risk factors for treatment failures in patients receiving PCR-based pre-emptive therapy for CMV infection","volume":"25","author":"Einsele","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1157\/13108710_bib86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/345441","article-title":"Trends in risk-profiles and mortality due to invasive aspergillosis in liver transplant recipients","volume":"36","author":"Singh","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib87","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/430602","article-title":"Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study","volume":"41","author":"Gavald\u00e1","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib88","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/319753","article-title":"Fusarium infection after solid-organ transplantation","volume":"32","author":"Sampathkumar","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib89","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V90.3.999","article-title":"Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten's years experience at a cancer center and implications for management","volume":"90","author":"Boutati","year":"1997","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1157\/13108710_bib90","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1470-9465.2004.00845.x","article-title":"Human fusariosis","volume":"10","author":"Dignani","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1157\/13108710_bib91","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1086\/324501","article-title":"Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infectons","volume":"33","author":"Anaissie","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib92","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/342328","article-title":"Cutaneous infection by Fusarium spp. in healthy and immunocompromised host: implications for diagnosis and management","volume":"35","author":"Nucci","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib93","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib94","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/13693780600752507","article-title":"Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist","volume":"44","author":"Guarro","year":"2006","journal-title":"Med Mycol"},{"key":"10.1157\/13108710_bib95","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/426445","article-title":"Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome","volume":"40","author":"Husain","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib96","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00005792-200209000-00001","article-title":"Pseudallescheria boydii (Anaphorm Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature","volume":"81","author":"Castiglioni","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1157\/13108710_bib97","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-3062.2001.30402.x","article-title":"Pulmonary Scedosporium infection following lung transplantation","volume":"3","author":"Tamm","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1157\/13108710_bib98","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1590\/S0100-879X2002000700005","article-title":"Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole","volume":"35","author":"Oliveira","year":"2002","journal-title":"Braz J Med Biol Res"},{"key":"10.1157\/13108710_bib99","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-200203000-00015","article-title":"Voriconazole in the treatment of aspergillosis, scedosporidiosis and other invasive fungal infections in children","volume":"21","author":"Walsh","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13108710_bib100","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/AAC.45.7.2151-2153.2001","article-title":"In vitro activities of tour novel triazoles against Scedosporium spp","volume":"45","author":"Carrillo","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13108710_bib101","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.50.3.917-921.2006","article-title":"Head to head comparison of the activities of currently available antifungal agents against 3378 Spanish clinical isolates of yeasts and filamentous fungi","volume":"50","author":"Cuenca-Estrella","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13108710_bib102","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00005792-199707000-00004","article-title":"Deep infections caused by Scedosporium prolificans: a report on 16 cases in Spain and a review of the literature","volume":"76","author":"Berenguer","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1157\/13108710_bib103","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1086\/338636","article-title":"Disseminated phaehyphomycosis: review o fan emerging mycosis","volume":"34","author":"Revankar","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib104","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/clinids\/11.5.741","article-title":"Disseminated zygomycosis. Report of tour cases and review","volume":"11","author":"Ingram","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1157\/13108710_bib105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib106","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-510X(96)00148-7","article-title":"Rhinocerebral and systemic mucormycosis: clinical experience with 36 cases","volume":"143","author":"Rangel-Guerra","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1157\/13108710_bib107","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0272-6386(12)80606-8","article-title":"Desferrioxamine therapy and mucormycosis in dialysis patients: reporto f an internacional registry","volume":"18","author":"Boelaert","year":"1991","journal-title":"Am J Kid Dis"},{"key":"10.1157\/13108710_bib108","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/clinids\/19.6.1133","article-title":"Cerebral mucormycosis associated with intravenous drug use: three case reports and review","volume":"19","author":"Hopkins","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib109","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-198603000-00004","article-title":"Improved diagnosis and prognosis of mucormycosis: a clinicopathological study of 33 cases","volume":"65","author":"Parfrey","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1157\/13108710_bib110","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib111","series-title":"Programa y Abstract de 45th Interscience Conference on Antimicrobial Agents and Chemotherapy","first-page":"16","article-title":"Epidemiology of invasive fungal infections (IFI) in Solid Organ (SOT) and Hematopoietic stem cell (HSCT) Transplant Recipients: a Prospective Study from RESITRA","author":"Gavald\u00e1","year":"2005"},{"key":"10.1157\/13108710_bib112","article-title":"Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis","volume":"89","author":"Kobayashi","year":"2004","journal-title":"Haematologica"},{"key":"10.1157\/13108710_bib113","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/427759","article-title":"Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia","volume":"40","author":"Oren","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib114","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1157\/13108710_bib115","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants","volume":"350","author":"Marty","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1157\/13108710_bib116","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/422723","article-title":"Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis","volume":"39","author":"Siwek","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib117","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","article-title":"Breakthrough fungal infections in stem cell transplant recipients receiving voriconazol","volume":"39","author":"Imhof","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib118","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1086\/427752","article-title":"Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required","volume":"40","author":"Vigoroux","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108710_bib119","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(05)67381-3","article-title":"Advances and challenges in management of invasive mycoses","volume":"366","author":"Patterson","year":"2005","journal-title":"Lancet"},{"key":"10.1157\/13108710_bib120","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00007890-200202150-00026","article-title":"Successful treatment of Mucor infection after liver or pancreas-kidney transplantation","volume":"73","author":"Jim\u00e9nez","year":"2002","journal-title":"Transplantation"},{"key":"10.1157\/13108710_bib121","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0163-4453(96)92986-2","article-title":"Invasive fungal infections in renal transplant recipients","volume":"33","author":"Nampoory","year":"1996","journal-title":"J Infect"},{"key":"10.1157\/13108710_bib122","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/clinids\/8.3.441","article-title":"Rhinocerebral mucormycosis in renal transplant recipients: report of three cases and review of the literature","volume":"8","author":"Morduchowicz","year":"1986","journal-title":"Rev Infect Dis"},{"key":"10.1157\/13108710_bib123","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/diabetes.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferring and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"10.1157\/13108710_bib124","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004630-199907000-00005","article-title":"Rhinocerebral mucormycosis in patients with burns: case report and review of the literature","volume":"20","author":"Stern","year":"1999","journal-title":"J Burn Care Rehabil"},{"key":"10.1157\/13108710_bib125","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0140-6736(05)71020-5","article-title":"Mucormycosis: an infectious complication of traumatic injury","volume":"365","author":"Hay","year":"2005","journal-title":"Lancet"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X07743306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X07743306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T20:43:46Z","timestamp":1587847426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X07743306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":125,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0213005X07743306"],"URL":"https:\/\/doi.org\/10.1157\/13108710","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}